Twist Synthetic SARS-CoV-2 RNA Control 15 (B.1.1.7_601443); Twist Synthetic SARS-CoV-2 RNA Control… and 3 more items

Twist Bioscience Corporation has been awarded a contract by the Commonwealth of Virginia's Department of General Services, effective July 14, 2026. The prime contractor will deliver synthetic SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RNA control materials for laboratory testing and validation purposes. The contract includes two distinct RNA control products: Twist Synthetic SARS-CoV-2 RNA Control 15 (B.1.1.7_601443) and Twist Synthetic SARS-CoV-2 RNA Control 16 (EPI_ISL_678597), each priced at $500 per unit with a quantity of one unit each. All deliverables are designated for delivery to Mackenzie Murphey, extension 296, at location T17.

The total contract value is $1,120.00, which includes the two RNA control products totaling $1,000.00 and ancillary services comprising $120.00 in combined shipping and handling charges ($70.00 for shipping and $50.00 for handling). These synthetic RNA controls are precision reagents used in diagnostic and research applications to ensure accuracy and reliability of coronavirus detection assays. The award does not specify an explicit period of performance beyond the award date; however, the contract terms reference Quote #Q-680892 as the underlying basis for pricing and delivery terms.